Angiogenesis in paediatric airway disease

Paediatric Respiratory Reviews

Volumn 3, Issue 3, 2002, Pages 219-229

  Wilson, John W ^a   Robertson, Colin F ^b  

^a ALFRED HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Angiogenesis; Asthma; Bronchial vessels; Cystic fibrosis; Growth factors

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CELL RECEPTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; RNA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ASTHMA; BRONCHIOLITIS; CELL MIGRATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MEDIATOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; RECEPTOR BINDING; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; REVIEW; RNA TRANSLATION; TARGET ORGAN; VASCULARIZATION; VASODILATATION;

EID: 0036426778     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(02)00200-2     Document Type: Review

References (141)

1. Williams H, McNicol KN. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study. BMJ 1969; 4: 321-325.
2. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138.
3. Horak E, Lanigan A, Roberts M et al. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ 2002 (in press).
4. Stevenson EC, Turner G, Heaney LG et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997; 27: 1027-1035.
5. Cutz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978; 2: 407 421.
6. Liebow AA, Hales MR, Lindskog GE. Enlargement of the bronchial arteries and their anastomoses with the pulmonary arteries in bronchiectasis. Am J Pathol 1949; 25: 211-231.
7. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978; 118: 759-781.
8. Widdicombe J. Physiologic control. Anatomy and physiology of the airway circulation. Am Rev Respir Dis 1992; 146: S3-S7.
9. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997; 27: 363-371 (see comments).
10. Baile EM, Guillemi S, Pare PD. Tracheobronchial and upper airway blood flow in dogs during thermally induced painting. J Appl Physiol 1987; 63: 2240-2246.
11. Baile EM, Pare PD. Methods of measuring bronchial blood flow. In Butler J (ed.) The Bronchial Circulation, vol. 57. New York: Marcel Dekker, 1992; pp. 101-180.
12. Schindt RF, Thews T. Human Physiology. Berlin: Springer, 1987.
13. Corfield DR, Hanafi Z, Webber SE, Widdicombe JG. Changes in tracheal mucosal thickness and blood flow in sheep. J Appl Physiol 1991; 71: 1282-1288.
14. Aviado DM. The bronchial circulation. In Aviado DM (ed.) The Lung Circulation. Oxford: Pergamon Press, 1965; pp. 185-254.
15. Butler J. The bronchial circulation. In Lenfant C (ed.) Lung Biology in Health and Disease. New York: Marcel Dekker, 1991.
16. McDonald DM. The ultrastructure and permeability of tracheobronchial blood vessels in health and disease. Eur Respir J 1990; 12 (supplement): 572s-585s.
17. Widdicombe J. Why are the airways so vascular? Thorax 1993; 48: 290-295.
18. Nagaishi C. Functional Anatomy and Histology or the Lung. Baltimore: University Park Press, 1972.
19. Laitiner A, Laitiner LA. Vascular beds in the airways of normal subjects and asthmatics. Eur Respir J 1990; 12(supplement): 658s-661s Discussion 661s-662s.
20. Berry JL, Brailsford JF, Daly IDB. The bronchial vascular system in the dog. Proc R Soc Lond 1931; 109: 214-228.
21. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994; 266: L61 -L83.
22. Laitinen A, Laitinen LA, Widdicombe J. Organisation and structure of the tracheal and bronchial blood vessels in the dog. J Anat 1989; 165: 133-140.
23. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
24. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156: 229-233.
25. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST, Early and late-phase bronchoconstriction after allergen challenge of non-anesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis 1988; 137: 548-557 (Published erratum appears in Am Rev Respir Dis 1990; 141: 518).
26. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
27. Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993; 133: 848-859.
28. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991.
29. Terman BI, Dougher Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579-1586.
30. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (flt- I) that confers endothelial-specific gene expression. J Biol Chem 1995; 270: 27948-27953.
31. Patterson C, Perrella MA, Hsieh CM, Yoshizumi M, Lee ME, Haber E. Cloning and functional analysis of the promoter for KDR/flk-I, a receptor for vascular endothelial growth factor. J Biol Chem 1995; 270: 23111-23118.
32. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993; 34: 159-161.
33. Solic N, Wilson S, Wilson J, Shute JK. Heparan sulphate expression is increased in CF compared to normal airway tissue. Pediatr Pulmonol 2000; 20(supplement): 266.
34. Drake CJ, Davis LA, Little CD, Antibodies to beta I -integrins cause alterations of aortic vasculogenesis, in vivo. Dev Dyn 1992; 193: 83-91.
35. Drake CJ, Cheresh DA, Little CD. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 1995; 108: 2655-2661.
36. Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol 1998; 177: 439-452.
37. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-I (ICAM- I) in the pathogenesis of asthma. Science 1990; 247: 456-459.
38. Rongish BJ, Hinchman G, Doty MK, Baldwin S, Tomanek RJ. Relationship of the extracellular matrix to coronary neovascularisation during development. J Mol Cell Cardiol 1996; 28: 2203-2215.
39. Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 1998; 31: 162-169.
40. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11: 457-465.
41. Thurston G, Maas K, Labarbara A, Mclean JW, McDonald DM. Microvascular remodelling in chronic airway inflammation in mice. Clin Exp Pharmacol Physiol 2000; 27: 836-841.
42. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992: 72: 369-417.
43. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
44. O'Reilly M, Silver GM, Gamelli RL, Davis JH, Hebert JC, Dose dependency of granulocyte-macrophage colony stimulating factor for improving survival following burn wound infection. J Trauma 1994; 36: 486-490.
45. Auerbach W, Auerbach R. Angiogenesis inhibition: a review, Pharmacol Ther 1994; 63: 265-311.
46. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J. Inhibition of angiogenesis in vivo by irterleukin 12. J Nat Cancer Inst 1995; 87: 581-586.
47. Angiolillo AL, Sgadari C, Tosato G. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann NY Acad Sci 1996; 795: 158-167.
48. Strieter RM. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2001; 2: 285-286.
49. Dunnill MS. The pathology of asthma, with special reference to the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
50. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-410.
51. Djukanovic R, Wilson JW, Lai CK, Holgate ST, Howarth PH. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991; 143: 772-777.
52. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural. Am Rev Respir Dis 1989; 140: 1745-1753.
53. Djukanovic R, Wilson JW, Britten KM et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-674.
54. Wilson JW, Djukanovic R, Howarth PH, Holgate ST. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis 1992; 145: 958-960.
55. Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54: 289-295.
56. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806-817.
57. Carroll NG, Cooke C, James AL. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997; 155: 689-695.
58. Newman PJ, Berndt MC, Gorski J et al. PECAM- I (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 1219-1222.
59. Erhard H, Rietveld FJ, Brocker EB, de Waal RM, Ruiter DJ. Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. J Invest Dermatol 1996; 106: 135-140.
60. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985; 52: 71-76.
61. de Waal RM, van Altena MC, Erhard H, Weidle UH, Nooijen PT, Ruiter DJ. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol 1997; 150: 1951-1957.
62. Wilson JW, Bamford TL. Assessing the evidence for remodelling of the airway in asthma. Pulm Pharmacol Ther 2001; 14: 229-247.
63. Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hemotol 1999; 31: 119-133.
64. Schmidt HH, Walter U. NO at work, Cell 1994; 78: 919-925.
65. Dinh Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992; 5: 757-762.
66. Texereau J, Nguyen Huu L, Dinh Xuan AT. Role of NO in asthma. Rev Pneumol Clin 1998; 54(supplement I): S9-S10.
67. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155: 297-307.
68. Holgate ST, Djukanovic R, Wilson J, Roche W, Britten K, Howarth PH. Allergic inflammation and its pharmacological modulation in asthma. Int Arch Allergy Appl Immunol 1991; 94: 210-217.
69. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78: 1701-1706.
70. Rubin AH, Smith LJ, Patterson R. The bronchoconstrictor properties of platelet-activating factor in humans. Am Rev Respir Dis 1987; 136: 1145-1151.
71. Evans TW, Chung KF, Rogers DF, Barnes PJ. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 1987; 63: 479-484.
72. Djukanovic R, Wilson JW, Britten KM et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871 (see comments).
73. Spry CJ, Kay AB, Gleich GJ, Eosinophils. Immunol Today 1992; 13: 384-387.
74. Lovett D, Kozan B, Hadam M, Resch K, Gemsa D. Macrophage cytotoxicity: interleukin I as a mediator of tumor cytostasis. J Immunol 1986; 136: 340-347.
75. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991; 87: 794-802.
76. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
77. Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986; 55: 289-294.
78. Jakobsson A, Norrby K. Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int J Exp Pathol 1994; 75: 43-50.
79. Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1980; 152: 931-944.
80. Roche WR. Mast cells and tumour angiogenesis: the tumor-mediated release of an endothelial growth factor from mast cells. Int J Cancer 1985; 36: 721-728.
81. D'Amore PA. Mechanisms of endothelial growth control. Am J Respir Cell Mol Biol 1992; 6: 1-8.
82. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Ann Rev Physiol 1991: 53: 217-239.
83. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 1988; 130: 393-400.
84. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858.
85. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-1478.
86. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997; 57: 765-772.
87. Roberts AB, Sporn MB. Transforming growth factor-betas. In Sporn MB, Roberts AB (eds) Handbook of Experimental Pharmacology. Heidelberg: Springer-Verlag, 1990; pp. 419-472.
88. Jennings JC, Mohan S, Linkhart TA, Widstrom R, Baylink DJ. Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol 1988; 137: 167-172.
89. Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 1990; 111: 757-763.
90. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
91. Toi M, Harris AL, Bicknell R. Interleukin-4 is a potent mitogen for capillary endothelium. Biochem Biophys Res Commun 1991; 174: 1287-1293.
92. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis? Cell 1989; 58: 803-805.
93. Ingber DE, Folkman J. Regulation of endothelial growth factor action: solid state control by extracellular matrix. Progr Clin Biol Res 1987; 249: 273-282.
94. Sumpio BE, Bares AJ, Levin LG, Johnson G Jr. Mechanical stress stimulates aortic endothelial cells to proliferate. J Vasc Surg 1987; 6: 252-256.
95. Tozzi CA, Poiani GJ, Harangozo AM, Boyd CD, Riley DJ. Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest 1989; 84: 1005-1012.
96. Wilson JW, Wilson GJ. The bronchial microcirculation. Clin Exp Allergy Rev 2001; 1: 120-122.
97. Brain SD, Williams TJ. Leukotrienes and inflammation. Pharmacol Ther 1990; 46: 57-66.
98. Feinmark SJ. Leukotriene C4 biosynthesis during polymorphonuclear leukocyte-vascular cell interactions. Methods Enzymol 1990; 187: 559-567.
99. Fermark SJ, Cannon PJ. Endothelial cell leuxotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986; 261: 16466-16472.
100. Bertrand C, Geppetti P, Baker J, Yamawaki I, Nadel JA. Role of neurogenic inflammation in antigen-induced vascular extravasation in guinea pig trachea. J Immunol 1993; 150: 1479-1485.
101. McDonald DM. Neurogenic inflammation in the rat trachea. I. Changes in venules. J Neurocytol 1988; 17: 583-603.
102. McDonald DM, Mitchell RA, Gabella G, Haskell A. Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability. J Neurocytol 1988; 17: 605-628.
103. Saria A, Lundberg JM. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 1983; 8: 41-49.
104. Perssor CG. Role of plasma exudation in asthmatic airways. Lancet 1986; 2: 1126-1129.
105. Hulstrom D, Svensjo E. Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer. J Parthol 1979; 129: 125-133.
106. Cotran RS, Suter ER, Majno G. The use of colloidal carbon as a tracer for vascular injury. A review. Vasc Dis 1967; 4: 107-127.
107. Laitinen LA, Laitinen A. Mucosal inflammation and bronchial hyperreactivity. Eur Respir J 1988; 1: 488-489.
108. McDonald DM. The concept of neurogenic inflammation in the respiratory tract. In Kaliner M, Barnes P, Kunkel G, Baraniuk J (eds) Neuropeptides in the Respiratory Medicine. New York: Marcel Dekker, 1994; pp. 321-349.
109. Salvato C. Some histological changes in chronic bronchitis and asthma. Thorox 1968; 23: 168-172.
110. Fox J, Galey F, Wayland H. Action of histamine on the mesenteric microvasculature. Microvasc Res 1980; 19: 108-126.
111. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol 1990; 431: 379-401.
112. Bowden JJ, McDonald DM. The microvasculature as a participant in inflammation. In Holgate S (ed.) Immunopharmacology of the Respiratory System. London: Academic Press, 1995; pp. 147-168.
113. Baluk P, Bowden JJ, Lefevre PM, McDonald DM. Upregulation of substance P receptors in angiogenesis associated with chronic airway inflammation in rats. Am J Physiol 1997; 273: L565-L571.
114. Perssor CG, Erjefalt I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990; 92: 148- 153.
115. Kondo M, Finkbeiner WE, Widdicombe JH. Changes in permeability of dog tracheal epithelium in response to hydrostatic pressure. Am J Physiol 1992; 262: L176-L182.
116. Yager D, Butler JP, Bastacky J, Israel E, Smith C, Drazen JM. Amplification of air-way constriction due to liquid filling of airway interstices. J Appl Physiol 1989; 66: 2873-2884.
117. Yager D, Kamm RD, Drazen JM. Airway wall liquid. Sources and role as an amplifier of bronchoconstriction. Chest 1995; 107: 105S-110S.
118. Webber SE, Widdicombe JG. The transport of albumin across the ferret in vitro whole trachea. J Physiol 1989; 408: 457-472.
119. Price AM, Webber SE, Widdicombe JG. Transport of albumin by the rabbit trachea in vitro. J Appl Physiol 1990; 68: 726-730.
120. De Burgh Daly I. Interference of intrinsic pulmonary mechanisms as a potential cause of asthma. Edinburgh Med J 1935; 43: 139-142.
121. Hogg JC, Pare PD, Moreno R. The effect of submucosal edema on airways resistance. Am Rev Respir Dis 1987; 135: S54-S56.
122. Wiggs BR, Moreno R, Hogg JC, Hilliam C, Pare PD. A model of the mechanics of airway narrowing. J Appl Physiol 1990; 69: 849-860.
123. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 1251-1258.
124. Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Pare PD. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993; 74: 2771-2781.
125. Lockhart A, Dinh Xuan AT, Regnard J, Cabanes L, Matran R. Effect of airway blood flow on airflow, Am Rev Respir Dis 1992; 146: S19-S23.
126. Mitzner W, Wagner E, Brown RH. Is asthma a vascular disorder? Chest 1995; 107: 97S- 102S.
127. Wilson JW, Li X, Pain MC. The lack of distensibility of asthmatic airways. Am Rev Respir Dis 1993; 148: 806-809.
128. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993; 148: 720-726.
129. Smith JC, Mitzner W, Elastic characteristics of the lung perivascular interstitial space. J Appl Physiol 1983; 54: 1717-1725.
130. Anonymous, Cardiac asthma. Lancet 1990; 335: 693-694.
131. Gleason DC, Steiner RE. The lateral roentgenogram in pulmonary edema. Am J Roentgenol Rad Ther Nucl Med 1966; 98: 279-290.
132. Cabanes LR, Weber SN, Matran R et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 1989; 320: 1317-1322.
133. Metzger WJ, Zavala D, Richerson HB et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway Inflammation. Am Rev Respir Dis 1987; 135: 433-440.
134. Long WM, Yerger LD, Martinez H et al. Modification of bronchial blood flow during allergic airway responses. J Appl Physiol 1988; 65: 272-282.
135. Alving K. Airways vasodilatation in the immediate allergic reaction. Involvement of inflammatory mediators and sensory nerves. Acta Physiol Scand 1991; 597(supplement): 1-64.
136. Laitinen LA, Robinson NP, Laitinen A, Widdicombe JG. Relationship between tracheal mucosal thickness and vascular resistance in dogs. J Appl Physiol 1986; 61: 2186-2193.
137. Kramer GC, Lindsey DC, Wu CH, Mertens S, Russell LA, Cross CE. Airway blood flow distribution and lung edema after histamine infusion in awake sheep. J Appl Physiol 1988; 65: 1847-1854.
138. Wagner EM, Mitzner WA. Effect of left atrial pressure or bronchial vascular hemodynamics. J Appl Physiol 1990; 69: 837-842.
139. Brown RH, Herold CJ, Hirshman CA, Zerhouni EA, Mitzner W. In vivo measurements of airway reactivity using high-resolution computed tomography. Am Rev Respir Dis 1991; 144: 208-212.
140. Brown RH, Herold CJ, Hirshman CA, Zerhouni EA, Mitzner W. Individual airway constrictor response heterogeneity to histamine assessed by high-resolution computed tomography. J Appl Physiol 1993; 74: 2615-2620.
141. Blosser S, Mitzner W, Wagner EM. Effects of increased bronchial blood flow on airway morphometry, resistance, and reactivity. J Appl Physiol 1994; 76: 1624-1629.